Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas
- PMID: 12461745
- DOI: 10.1002/gcc.10132
Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas
Abstract
Conventional cytogenetic studies have shown that osteosarcomas (OSs) are often highly aneuploid, with a large number of both structural and numerical chromosomal alterations. To investigate the complexity of OS karyotypes in detail, we applied spectral karyotyping (SKY) to a series of 14 primary OS tumors and four established OS cell lines. A total of 531 rearrangements were identified by SKY, of which 300 breakpoints could be assigned to a specific chromosome band. There was an average of 38.5 breakpoints identified by SKY per primary tumor. Chromosome 20 was involved in a disproportionately high number of structural rearrangements, with 38 different aberrations being detected. Chromosomal rearrangements between chromosomes 20 and 8 were evident in four tumors. FISH analysis using a 20q13 subtelomeric probe identified frequent involvement of 20q in complex structural rearrangements of OS cell lines. Characterization of the structural aberrations of chromosomes 8 and 17 by use of SKY demonstrated frequent duplication or partial gains of chromosome bands 8q23-24 and 17p11-13. Other chromosomes frequently involved in structural alteration were chromosomes 1 (47 rearrangements) and 6 (38 rearrangements). Centromeric rearrangements often involving chromosomes 1, 6, 13, 14, 17, and 20 were present. Four of the 14 primary OS tumors were characterized by nonclonal changes that included both structural and numerical alterations. In summary, OS tumors have a very high frequency of structural and numerical alterations, compounded by gross changes in ploidy. This intrinsic karyotype instability leads to a diversity of rearrangements and the acquisition of composite chromosomal rearrangements, with the highest frequency of alteration leading to gain of 8q23-24 and 17p11-13 and rearrangement of 20q. These findings suggest that specific sequences mapping to these chromosomal regions will likely have a role in the development and progression of OS.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma.Genes Chromosomes Cancer. 2004 Jan;39(1):11-21. doi: 10.1002/gcc.10291. Genes Chromosomes Cancer. 2004. PMID: 14603437
-
Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63.Cancer Genet Cytogenet. 2004 Sep;153(2):158-64. doi: 10.1016/j.cancergencyto.2004.01.016. Cancer Genet Cytogenet. 2004. PMID: 15350306
-
Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours.Int J Oncol. 2004 Jun;24(6):1385-91. Int J Oncol. 2004. PMID: 15138578
-
Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations.Cytogenet Genome Res. 2007;118(2-4):148-56. doi: 10.1159/000108295. Cytogenet Genome Res. 2007. PMID: 18000365 Review.
-
Analysis of a de novo complex chromosome rearrangement involving chromosomes 4, 11, 12 and 13 and eight breakpoints by conventional cytogenetic, fluorescence in situ hybridization and spectral karyotyping.Prenat Diagn. 1999 Dec;19(12):1143-9. Prenat Diagn. 1999. PMID: 10590433 Review.
Cited by
-
Genome-Informed Targeted Therapy for Osteosarcoma.Cancer Discov. 2019 Jan;9(1):46-63. doi: 10.1158/2159-8290.CD-17-1152. Epub 2018 Sep 28. Cancer Discov. 2019. PMID: 30266815 Free PMC article.
-
Using Liquid Biopsy in the Treatment of Patient with OS.Adv Exp Med Biol. 2020;1257:95-105. doi: 10.1007/978-3-030-43032-0_9. Adv Exp Med Biol. 2020. PMID: 32483734 Review.
-
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.Crit Rev Oncog. 2015;20(3-4):173-97. doi: 10.1615/critrevoncog.2015013713. Crit Rev Oncog. 2015. PMID: 26349415 Free PMC article. Review.
-
Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation.Virchows Arch. 2007 Sep;451(3):691-9. doi: 10.1007/s00428-007-0426-3. Epub 2007 Jul 26. Virchows Arch. 2007. PMID: 17653762
-
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force.Pediatr Blood Cancer. 2021 Sep;68(9):e29188. doi: 10.1002/pbc.29188. Epub 2021 Jun 16. Pediatr Blood Cancer. 2021. PMID: 34137164 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical